[Paragon Genomics] Saphetor and Paragon Genomics announce partnership to accelerate NGS-based precision diagnostics
2020-05-06
Saphetor and Paragon Genomics announce partnership to accelerate NGS-based precision diagnostics
[ScaleFlux] ScaleFlux® Runs Virtual Booth at Aerospike Summit 2020!
2020-05-12
the csd 2000 series is the best flash storage for the fastest nosql database.
[Paragon Genomics] Paragon Genomics Introduces CleanPlex® SARS-CoV-2 NGS Panel for Research and Surveillance of COVID-19 Coronavirus
2020-03-19
Highly Multiplexed Target Enrichment Panel Covers Entire Genome of the New Coronavirus to Facilitate Complete Genome Sequencing and Support Epidemiological Studies. / CleanPlex Technology Converts Viral RNA to Sequence-Ready Libraries with Excellent Sensitivity in Just 5 Hours Using a Streamlined and Efficient Workflow.
[NeuCyte] NeuCyte Licenses Promising Novel Compound for Treatment of Refractory Epilepsy and Related Neurological Disorders
2019-09-25
San Carlos, Calif., USA, September 24th, 2019—NeuCyte, Inc., an innovative biotech company focused on developing novel treatments for neurological disorders, today announced that it has entered into an exclusive license agreement with Trillium Therapeutics to advance an undisclosed preclinical compound with potential utility in treating refractory epilepsy in the form of Dravet syndrome and related disorders.
[NeuCyte] NeuCyte and REPROCELL enter distribution agreement in North America and Europe
2019-09-25